1
|
Sakorafas GH, Milingos D and Peros G:
Asymptomatic cholelithiasis: Is cholecystectomy really needed? A
critical reappraisal 15 years after the introduction of
laparoscopic cholecystectomy. Dig Dis Sci. 52:1313–1325. 2007.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Ruhl CE and Everhart JE: Gallstone disease
is associated with increased mortality in the United States.
Gastroenterology. 140:508–516. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Matveeva SA: The role of lipid-protein
interplay in the development of atherogenesis during coronary heart
disease and metabolic syndrome. Klin Med (Mosk). 90:30–34. 2012.(In
Russian). PubMed/NCBI
|
4
|
Ahmed MH, Barakat S and Almobarak AO: The
association between renal stone disease and cholesterol gallstones:
The easy to believe and not hard to retrieve theory of the
metabolic syndrome. Ren Fail. 36:957–962. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Chuang SC, Hsi E and Lee KT: Genetics of
gallstone disease. Adv Clin Chem. 60:143–185. 2013. View Article : Google Scholar : PubMed/NCBI
|
6
|
Allen NB, Lloyd-Jones D, Hwang SJ,
Rasmussen-Torvik L, Fornage M, Morrison AC, Baldridge AS,
Boerwinkle E, Levy D, Cupples LA, et al: Genetic loci associated
with ideal cardiovascular health: A meta-analysis of genome-wide
association studies. Am Heart J. 175:112–120. 2016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Kwon CH, Kang JG, Lee HJ, Kim NH, Sung JW,
Cheong E and Sung KC: Absence of association between gallstone and
coronary artery calcification. Atherosclerosis. 258:51–55. 2017.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Zheng Y, Xu M, Li Y, Hruby A, Rimm EB, Hu
FB, Wirth J, Albert CM, Rexrode KM, Manson JE and Qi L: Gallstones
and risk of coronary heart disease: Prospective analysis of 270000
men and women from 3 US cohorts and meta-analysis. Arterioscler
Thromb Vasc Biol. 36:1997–2003. 2016. View Article : Google Scholar : PubMed/NCBI
|
9
|
Lv J, Qi L, Yu C, Guo Y, Bian Z, Chen Y,
Yang L, Shen J, Wang S, Li M, et al: Gallstone disease and the risk
of ischemic heart disease. Arterioscler Thromb Vasc Biol.
35:2232–2237. 2015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Athanasiou T, Alruzzeh S, Kumar P,
Crossman MC, Amrani M, Pepper JR, Del Stanbridge R, Casula R and
Glenville B: Off-pump myocardial revascularization is associated
with less incidence of stroke in elderly patients. Ann Thorac Surg.
77:745–753. 2004. View Article : Google Scholar : PubMed/NCBI
|
11
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–788. 1986.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
13
|
Lee YS, Jang SE, Lee BS, Lee SJ, Lee MG,
Park JK, Lee SH, Ryu JK, Kim YT, Yoon YB and Hwang JH: Presence of
coronary artery disease increases the risk of biliary events in
patients with asymptomatic gallstones. J Gastroenterol Hepatol.
28:1578–1583. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Olaiya MT, Chiou HY, Jeng JS, Lien LM and
Hsieh FI: Significantly increased risk of cardiovascular disease
among patients with gallstone disease: A population-based cohort
study. PLoS One. 8:e764482013. View Article : Google Scholar : PubMed/NCBI
|
15
|
Wang JY, Lu FH, Sun ZJ, Wu JS, Yang YC,
Lee CT and Chang CJ: Gallstone disease associated with increased
risk of arterial stiffness in a Taiwanese population. J Hum
Hypertens. 31:616–619. 2017. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wei CY, Chung TC, Chen CH, Lin CC, Sung
FC, Chung WT, Kung WM, Hsu CY and Yeh YH: Gallstone disease and the
risk of stroke: A nationwide population-based study. J Stroke
Cerebrovasc Dis. 23:1813–1820. 2014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Wirth J, di Giuseppe R, Wientzek A, Katzke
VA, Kloss M, Kaaks R, Boeing H and Weikert C: Presence of
gallstones and the risk of cardiovascular diseases: The
EPIC-Germany cohort study. Eur J Prev Cardiol. 22:326–334. 2015.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Khan HN, Harrison M, Bassett EE and Bates
T: A 10-year follow-up of a longitudinal study of gallstone
prevalence at necropsy in South East England. Dig Dis Sci.
54:2736–2741. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Bortnichak EA, Freeman DH Jr, Ostfeld AM,
Castelli WP, Kannel WB, Feinleib M and McNamara PM: The association
between cholesterol cholelithiasis and coronary heart disease in
Framingham, Massachusetts. Am J Epidemiol. 121:19–30. 1985.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Dua A, Aziz A, Desai SS, McMaster J and
Kuy S: National trends in the adoption of laparoscopic
cholecystectomy over 7 Years in the United States and impact of
laparoscopic approaches stratified by age. Minim Invasive Surg.
2014:6354612014.PubMed/NCBI
|
21
|
Fan LL, Chen BH and Dai ZJ: The relation
between gallstone disease and cardiovascular disease. Sci Rep.
7:151042017. View Article : Google Scholar : PubMed/NCBI
|
22
|
Liu J, Lin H, Zhang C, Wang L, Wu S, Zhang
D, Tang F, Xue F and Liu Y: Non-alcoholic fatty liver disease
associated with gallstones in females rather than males: A
longitudinal cohort study in Chinese urban population. BMC
Gastroenterol. 14:2132014. View Article : Google Scholar : PubMed/NCBI
|
23
|
Sieron D, Czerny B, Sieron-Stoltny K,
Karasiewicz M, Bogacz A, Seremak-Mrozikiewicz A, Kotrych D, Boron D
and Mrozikiewicz P: The effect of chronic estrogen application on
bile and gallstone composition in women with cholelithiasis.
Minerva Endocrinol. 41:19–27. 2016.PubMed/NCBI
|
24
|
Upala S, Sanguankeo A and Jaruvongvanich
V: Gallstone disease and the risk of cardiovascular disease: A
systematic review and meta-analysis of observational studies. Scand
J Surg. 106:21–27. 2017. View Article : Google Scholar : PubMed/NCBI
|
25
|
Ahmed MH, Hamad MA, Routh C and Connolly
V: Statins as potential treatment for cholesterol gallstones: An
attempt to understand the underlying mechanism of actions. Expert
Opin Pharmacother. 12:2673–2681. 2011. View Article : Google Scholar : PubMed/NCBI
|
26
|
Yamada T, Hara K and Kadowaki T: Chewing
betel quid and the risk of metabolic disease, cardiovascular
disease, and all-cause mortality: A meta-analysis. PLoS One.
8:e706792013. View Article : Google Scholar : PubMed/NCBI
|
27
|
Shen HC, Hu YC, Chen YF and Tung TH:
Prevalence and associated metabolic factors of gallstone disease in
the elderly agricultural and fishing population of Taiwan.
Gastroenterol Res Pract. 2014:8769182014. View Article : Google Scholar : PubMed/NCBI
|
28
|
Zidi W, Allal-Elasmi M, Zayani Y, Zaroui
A, Guizani I, Feki M, Mourali MS, Mechmeche R and Kaabachi N:
Metabolic syndrome, independent predictor for coronary artery
disease. Clin Lab. 61:1545–1552. 2015. View Article : Google Scholar : PubMed/NCBI
|
29
|
Chen LY, Qiao QH, Zhang SC, Chen YH, Chao
GQ and Fang LZ: Metabolic syndrome and gallstone disease. World J
Gastroenterol. 18:4215–4220. 2012. View Article : Google Scholar : PubMed/NCBI
|
30
|
Fiorito G, Vlaanderen J, Polidoro S,
Gulliver J, Galassi C, Ranzi A, Krogh V, Grioni S, Agnoli C,
Sacerdote C, et al: Oxidative stress and inflammation mediate the
effect of air pollution on cardio- and cerebrovascular disease: A
prospective study in nonsmokers. Environ Mol Mutagen. 59:234–246.
2018. View
Article : Google Scholar : PubMed/NCBI
|
31
|
Maurer KJ, Carey MC and Fox JG: Roles of
infection, inflammation, and the immune system in cholesterol
gallstone formation. Gastroenterology. 136:425–440. 2009.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Lv JX, Kong Q and Ma X: Current advances
in circulating inflammatory biomarkers in atherosclerosis and
related cardio-cerebrovascular diseases. Chronic Dis Transl Med.
3:207–212. 2017. View Article : Google Scholar : PubMed/NCBI
|
33
|
Wu T, Zhang Z, Liu B, Hou D, Liang Y,
Zhang J and Shi P: Gut microbiota dysbiosis and bacterial community
assembly associated with cholesterol gallstones in large-scale
study. BMC Genomics. 14:6692013. View Article : Google Scholar : PubMed/NCBI
|
34
|
Tang WH, Kitai T and Hazen SL: Gut
microbiota in cardiovascular health and disease. Circ Res.
120:1183–1196. 2017. View Article : Google Scholar : PubMed/NCBI
|
35
|
Wang Z and Zhao Y: Gut microbiota derived
metabolites in cardiovascular health and disease. Protein Cell. May
3–2018.(Epub ahead of print). View Article : Google Scholar
|
36
|
Ahmadmehrabi S and Tang WHW: Gut
microbiome and its role in cardiovascular diseases. Curr Opin
Cardiol. 32:761–766. 2017. View Article : Google Scholar : PubMed/NCBI
|
37
|
Cai JS and Chen JH: The mechanism of
enterohepatic circulation in the formation of gallstone disease. J
Membr Biol. 247:1067–1082. 2014. View Article : Google Scholar : PubMed/NCBI
|
38
|
Wang Q, Jiao L, He C, Sun H, Cai Q, Han T
and Hu H: Alteration of gut microbiota in association with
cholesterol gallstone formation in mice. BMC Gastroenterol.
17:742017. View Article : Google Scholar : PubMed/NCBI
|
39
|
Neri V, Margiotta M, de Francesco V,
Ambrosi A, Valle ND, Fersini A, Tartaglia N, Minenna MF,
Ricciardelli C, Giorgio F, et al: DNA sequences and proteic
antigens of H. pylori in cholecystic bile and tissue of patients
with gallstones. Aliment Pharmacol Ther. 22:715–720. 2005.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Nam SY, Ryu KH, Park BJ and Park S:
Effects of Helicobacter pylori infection and its eradication on
lipid profiles and cardiovascular diseases. Helicobacter.
20:125–132. 2015. View Article : Google Scholar : PubMed/NCBI
|
41
|
Kozyrieva T, Kolesnikova E and Shut I:
Correlation of helicobacter pylori infection with development of
cardiovascular risk in patients with coronary heart disease in
association with type 2 diabetes mellitus. Georgian Med News.
24–29. 2016.PubMed/NCBI
|
42
|
Xu HL, Cheng JR, Andreotti G, Gao YT,
Rashid A, Wang BS, Shen MC, Chu LW, Yu K and Hsing AW: Cholesterol
metabolism gene polymorphisms and the risk of biliary tract cancers
and stones: A population-based case-control study in Shanghai,
China. Carcinogenesis. 32:58–62. 2011. View Article : Google Scholar : PubMed/NCBI
|
43
|
Srivastava A, Garg N, Srivastava A,
Srivastava K and Mittal B: Effect of genetic variant (rs11887534)
in ABCG8 gene in coronary artery disease and response to
atorvastatin therapy. Dis Markers. 28:307–313. 2010. View Article : Google Scholar : PubMed/NCBI
|
44
|
Xue P, Niu WQ, Jiang ZY, Zheng MH and Fei
J: A meta-analysis of apolipoprotein E gene ε2/ε3/ε4 polymorphism
for gallbladder stone disease disease. PLoS One. 7:e458492012.
View Article : Google Scholar : PubMed/NCBI
|
45
|
El-Lebedy D, Raslan HM and Mohammed AM:
Apolipoprotein E gene polymorphism and risk of type 2 diabetes and
cardiovascular disease. Cardiovasc Diabetol. 15:122016. View Article : Google Scholar : PubMed/NCBI
|